How much funding has Proteinea raised?

Proteinea has raised $250K in total funding, most recently a Seed round.

Who are Proteinea's investors?

Proteinea's investors include IndieBio.

Where is Proteinea headquartered?

Proteinea is headquartered in Cambridge, Massachusetts, Egypt.

What industry is Proteinea in?

Proteinea operates in Biotech, Healthcare, Artificial Intelligence.

Proteinea

Rewiring immune function with precision engineered antibodies

Cambridge, Egypt · Founded 2020 · $250K raised

Biotech

Healthcare

Artificial Intelligence

Headquarters: Cambridge, Massachusetts
Employees: 11–50
Founded: 2020
Business Model: B2B

Website: www.proteinea.com
Total Funding: $250K
Last Round: $250K SeedMar 2021
Rounds: 1

About

Proteinea is a TechBio company transforming drug discovery and development by integrating advanced biotechnology with artificial intelligence. The company specializes in rational engineering of antibody Fc domains to enable context-specific immune tuning, enhanced half-life, and targeted biodistribution, combining AI-driven prediction with therapeutic insight. Proteinea's proprietary AI models and computational tools engineer next-generation antibodies with improved efficacy, safety, and manufacturability, with operations in Cambridge MA, Cairo, KAUST, and Munich.

Summary

Proteinea is a Biotech company based in Cambridge, Egypt, founded in 2020. It has raised $250K in total across 1 round, most recently a $250K Seed round in Mar 2021. Investors include IndieBio.